MetaCap

PMGC (ELAB) vs Onconetix (ONCO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Onconetix is the larger company by market cap ($3.2 million vs $2.5 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELAB-0.48%ONCO+9.56%
+10%+5%-1%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELAB versus ONCO key metrics
MetricELABONCO
Share price$3.08$0.62
Market cap$2.49M$3.25M
1-day change-0.96%-5.24%
P/E ratio (TTM)—0.00
EPS (TTM)$-1,748.36$310.39
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2,671.20$207.00
52-week low$2.59$0.58
Distance from 52-week high-99.88%-99.70%
Average volume127.38K2.96M
Shares outstanding809.58K5.24M
Employees322
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About PMGC

ELAB stock →

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.

Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees

About Onconetix

ONCO stock →

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

ELAB vs ONCO FAQ

Which is bigger, PMGC or Onconetix?

Onconetix (ONCO) is larger, with a market capitalization of $3.25M compared with $2.49M for PMGC (ELAB).

Are PMGC and Onconetix in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons